Alterations of Platelet Aggregation Kinetics with Ultraviolet Laser Emission: The “Stunned Platelet” Phenomenon

Platelets, a major constituent of thrombus, play a crucial role in the pathogenesis of acute ischemic coronary syndromes. The effect of ultraviolet laser emission on platelets within thrombi is unknown. The effects of increasing levels of laser energy on platelets in whole blood were investigated. Blood samples were obtained by aseptic venipuncture and anticoagulated with 3.8% sodium citrate. Samples were exposed to increased levels (0, 30, 45, 60 mJ/mm2; 25 Hz) of ultraviolet excimer laser fluence (308 nm wave-length) and then tested for ADP and collagen induced platelet aggregation, platelet concentration, and for platelet contractile force (PCF) development. Scanning electron microscopy was used to detect laser induced morphologic changes of platelets and by flow cytometric analysis to detect changes in expression of platelet surface antigens p-selectin (CD 62) and glycoprotein IIb/IIIa (CD 43). Exposure to excimer laser energy produced dose dependent suppression of platelet aggregation and force development ("stunned platelets"). ADP aggregation decreased from 8.0+/-1.1 Ohms (mean+/-SEM) to 3.7+/-0.8 Ohms (p<0.001) to 2.7+/-0.6 Ohms (p <0.001) and to 1.8+/-0.5 Ohms (p <0.001) as the laser energy increased from 0 to 30 to 45 to 60 mJ/mm2, respectively. Collagen induced aggregation decreased from 21.4+/-1.4 Ohms to 15.7+/-1.2 Ohms (p <0.001) to 11.7+/-1.1 Ohms (p <0.001) and to 9.9+/-1.0 Ohms (p <0.001), in response to the same incremental range of laser energy. Platelet contractile forces declined from 34,500+/-3700 to 27.800+/-2700 dynes as laser energy increased from 0 to 60 mJ/mm2 (p <0.03). Platelet concentration did not change with increasing laser energy. The expression of platelet surface antigen p-selectin (CD 62) remained stable through increasing levels of laser energy exposures while the percentage of CD 43 positive platelets significantly increased with exposure to laser energy, yet the level of expression did not exceed 0.5% of cells. Thus, aggregation kinetics are altered in platelets exposed to ultraviolet laser energy as manifested by decreased platelet aggregation and reduction in platelet force development capability. The response is dose dependent and most pronounced at higher energy levels such as 60 mJ/mm2.

[1]  Carr Me.  Measurement of platelet force: the Hemodyne hemostasis analyzer. , 1995 .

[2]  P. Doerger,et al.  The effects of argon laser on in vitro aggregation of platelets in platelet rich plasma and whole blood. , 1988, Thrombosis research.

[3]  M. Leon,et al.  Percutaneous excimer laser coronary angioplasty: results in the first consecutive 3,000 patients. The ELCA Investigators. , 1994, Journal of the American College of Cardiology.

[4]  Eric J. Topol,et al.  Textbook of Interventional Cardiology , 1999 .

[5]  F. Mohr,et al.  Role of laser and thermal ablation devices in the treatment of vascular diseases. , 1988, The American journal of cardiology.

[6]  A. Lansky,et al.  Effectiveness of excimer laser coronary angioplasty in acute myocardial infarction or in unstable angina pectoris. , 2001, The American journal of cardiology.

[7]  O. Topaz,et al.  Solid‐state mid‐infrared laser facilitated coronary angioplasty: Clinical and quantitative coronary angiographic results in 112 patients , 1996, Lasers in surgery and medicine.

[8]  V. Fuster,et al.  The pathogenesis of coronary artery disease and the acute coronary syndromes (2). , 1992, The New England journal of medicine.

[9]  V. Fuster,et al.  Lewis A. Conner Memorial Lecture. Mechanisms leading to myocardial infarction: insights from studies of vascular biology. , 1994, Circulation.

[10]  J. Eidt,et al.  Specific Platelet Mediators and Unstable Coronary Artery Lesions: Experimental Evidence and Potential Clinical Implications , 1989, Circulation.

[11]  D. Shepro,et al.  Similarities between platelet contraction and cellular motility during mitosis: role of platelet microtubules in clot retraction. , 1976, Journal of cell science.

[12]  Epic Investigators,et al.  Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty. , 1994, The New England journal of medicine.

[13]  E. Morgenstern,et al.  Platelets and fibrin strands during clot retraction. , 1984, Thrombosis research.

[14]  O. Topaz.  Plaque removal and thrombus dissolution with the photoacoustic energy of pulsed-wave lasers-biotissue interactions and their clinical manifestations. , 1996, Cardiology.

[15]  E. Topol,et al.  Abrupt vessel closure complicating coronary angioplasty: clinical, angiographic and therapeutic profile. , 1992, Journal of the American College of Cardiology.

[16]  F. Dewerf.  More evidence for a beneficial effect of platelet glycoprotein IIb/IIIa-blockade during coronary interventions. Latest results from the EPILOG and CAPTURE trials. , 1996 .

[17]  J. White,et al.  Ultrastructure of clots during isometric contraction , 1982, The Journal of cell biology.

[18]  M. Carr,et al.  Glycoprotein IIb/IIIa Blockade Inhibits Platelet-mediated Force Development and Reduces Gel Elastic Modulus , 1995, Thrombosis and Haemostasis.

[19]  E. Perin,et al.  Excimer Laser Revascularisation: Current Indications, Applications and Techniques , 2001, Lasers in Medical Science.

[20]  T. Ryan,et al.  Excimer laser-assisted coronary angioplasty for lesions containing thrombus. , 1993, Journal of the American College of Cardiology.

[21]  H. Hecht,et al.  Unstable angina and coronary angioplasty. , 1990, Circulation.

[22]  Bittl Ja.  Clinical results with excimer laser coronary angioplasty. , 1996 .

[23]  Schneider Dj,et al.  Optimizing antiplatelet therapy in patients with acute coronary syndromes: a role for monitoring platelet reactivity. , 1999 .

[24]  M. Carr,et al.  Force monitoring of clot retraction during DDAVP therapy for the qualitative platelet disorder of uraemia: report of a case , 1991, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[25]  M. Carr,et al.  Measurement of platelet-mediated force development during plasma clot formation. , 1991, The American journal of the medical sciences.

[26]  P. Elwood,et al.  Ischemic heart disease and platelet aggregation. The Caerphilly Collaborative Heart Disease Study. , 1991, Circulation.

[27]  E. Falk.  Unstable angina with fatal outcome: dynamic coronary thrombosis leading to infarction and/or sudden death. Autopsy evidence of recurrent mural thrombosis with peripheral embolization culminating in total vascular occlusion. , 1985, Circulation.